Ocular Therapeutix Inc (OCUL)
5.66
-0.18
(-3.08%)
USD |
NASDAQ |
May 10, 16:00
5.65
-0.01
(-0.18%)
After-Hours: 20:00
Ocular Therapeutix Cash from Investing (TTM): -2.963M for March 31, 2024
Cash from Investing (TTM) Chart
Historical Cash from Investing (TTM) Data
Date | Value |
---|---|
March 31, 2024 | -2.963M |
December 31, 2023 | -6.087M |
September 30, 2023 | -7.778M |
June 30, 2023 | -8.313M |
March 31, 2023 | -6.818M |
December 31, 2022 | -3.715M |
September 30, 2022 | -2.196M |
June 30, 2022 | -1.678M |
March 31, 2022 | -1.312M |
December 31, 2021 | -1.194M |
September 30, 2021 | -0.816M |
June 30, 2021 | -0.754M |
March 31, 2021 | -0.75M |
December 31, 2020 | -0.841M |
September 30, 2020 | -1.189M |
June 30, 2020 | -1.394M |
March 31, 2020 | -1.762M |
December 31, 2019 | -2.238M |
September 30, 2019 | -2.116M |
June 30, 2019 | -2.17M |
March 31, 2019 | -2.233M |
Date | Value |
---|---|
December 31, 2018 | -1.889M |
September 30, 2018 | -1.974M |
June 30, 2018 | -0.532M |
March 31, 2018 | 18.73M |
December 31, 2017 | 26.95M |
September 30, 2017 | 16.64M |
June 30, 2017 | 26.99M |
March 31, 2017 | 20.04M |
December 31, 2016 | 37.07M |
September 30, 2016 | 45.86M |
June 30, 2016 | 6.957M |
March 31, 2016 | 4.158M |
December 31, 2015 | -38.57M |
September 30, 2015 | -74.25M |
June 30, 2015 | -46.94M |
March 31, 2015 | -56.14M |
December 31, 2014 | -38.59M |
September 30, 2014 | -1.025M |
June 30, 2014 | -0.86M |
March 31, 2014 | -0.663M |
December 31, 2013 | -0.387M |
Cash From Investing Definition
Cash from Investing is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall investing activities of the company. A few examples of investing activities include net change in PP&E, and net divestitures.
Cash from Investing (TTM) Range, Past 5 Years
-8.313M
Minimum
Jun 2023
-0.75M
Maximum
Mar 2021
-2.804M
Average
-1.939M
Median
Cash from Investing (TTM) Benchmarks
Amgen Inc | -27.78B |
Assertio Holdings Inc | 3.202M |
CytomX Therapeutics Inc | -150.67M |
EyePoint Pharmaceuticals Inc | -3.315M |
Cormedix Inc | -17.06M |